BR112012014678A2 - "uso do dna mrna, método para o diagnóstico da rosácea e método de monitoramento" - Google Patents
"uso do dna mrna, método para o diagnóstico da rosácea e método de monitoramento"Info
- Publication number
- BR112012014678A2 BR112012014678A2 BR112012014678A BR112012014678A BR112012014678A2 BR 112012014678 A2 BR112012014678 A2 BR 112012014678A2 BR 112012014678 A BR112012014678 A BR 112012014678A BR 112012014678 A BR112012014678 A BR 112012014678A BR 112012014678 A2 BR112012014678 A2 BR 112012014678A2
- Authority
- BR
- Brazil
- Prior art keywords
- rosacea
- diagnosis
- monitoring method
- dna mrna
- mrna
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28211309P | 2009-12-17 | 2009-12-17 | |
PCT/EP2010/069896 WO2011073321A1 (en) | 2009-12-17 | 2010-12-16 | Markers and method for the diagnosis of rosacea |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012014678A2 true BR112012014678A2 (pt) | 2016-04-05 |
Family
ID=43417037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012014678A BR112012014678A2 (pt) | 2009-12-17 | 2010-12-16 | "uso do dna mrna, método para o diagnóstico da rosácea e método de monitoramento" |
Country Status (12)
Country | Link |
---|---|
US (1) | US20130017969A1 (pt) |
EP (1) | EP2513328A1 (pt) |
JP (1) | JP2013514070A (pt) |
KR (1) | KR20120115321A (pt) |
CN (1) | CN102762742A (pt) |
AU (1) | AU2010332876A1 (pt) |
BR (1) | BR112012014678A2 (pt) |
CA (1) | CA2783693A1 (pt) |
IN (1) | IN2012DN06279A (pt) |
MX (1) | MX2012006623A (pt) |
RU (1) | RU2012130069A (pt) |
WO (1) | WO2011073321A1 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2723893B1 (en) * | 2011-06-27 | 2018-11-21 | Galderma Research & Development | New th-17 differentiation markers for rosacea and uses thereof |
EP2723892A2 (en) * | 2011-06-27 | 2014-04-30 | Galderma Research & Development | New th-17 differentiation markers for rosacea and uses thereof |
WO2013060865A1 (en) * | 2011-10-28 | 2013-05-02 | Galderma Research & Development | New leukocyte infiltrate markers for rosacea and uses thereof |
CA2857751A1 (en) * | 2011-12-16 | 2013-06-20 | Galderma Research & Development | Method for the diagnosis of rosacea |
US9860241B2 (en) * | 2014-04-15 | 2018-01-02 | Level 3 Communications, Llc | Device registration, authentication, and authorization system and method |
KR101712747B1 (ko) | 2015-11-06 | 2017-03-07 | 가톨릭대학교 산학협력단 | 유파틸린을 유효성분으로 포함하는 피부질환 예방 또는 치료용 조성물 |
CN106119348B (zh) * | 2016-06-27 | 2018-02-23 | 中南大学湘雅医院 | 一种以非编码lnc‑CXCL1及编码基因cxcl1组合为检测或诊断筛查标志物的重症肌无力检测试剂盒及应用 |
KR102216941B1 (ko) * | 2020-08-12 | 2021-02-18 | 주식회사 큐티스의생명연구센터 | 마이크로니들 패치를 포함하는 최소 침습적 홍조성 민감피부 평가 키트 및 홍조성 민감피부 평가를 위한 바이오마커 |
JP2022554046A (ja) * | 2020-08-10 | 2022-12-28 | カティス バイオメディカル リサーチ センター | マイクロニードルパッチを含む最小侵襲的皮膚状態の診断キット |
CN113462770B (zh) * | 2021-08-25 | 2023-03-31 | 中国医科大学附属第一医院 | 趋化因子作为玫瑰痤疮诊断的分子标志物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090118141A1 (en) * | 2005-05-04 | 2009-05-07 | The Regents Of The University Of California | Methods of oligosaccharide profiling for the detection of ocular rosacea |
WO2007077257A2 (en) * | 2006-01-05 | 2007-07-12 | Galderma Research & Development | Acne lesions biomarkers and modulators thereof |
US20090318534A1 (en) * | 2006-09-27 | 2009-12-24 | The Regents Of The University Of California | Methods and compositions for the treatment of skin diseases and disorders |
WO2009053493A1 (en) * | 2007-10-26 | 2009-04-30 | Galderma Research & Development | Non-invasive method to perform skin inflammatory disease pharmaco-genomic studies and diagnosis method thereof |
FR2923610B1 (fr) | 2007-11-14 | 2009-11-27 | Galderma Res & Dev | Methode non-invasive de recueil de donnees biologiques pour l'etablissement d'un diagnostic d'une pathologie cutanee. |
-
2010
- 2010-12-16 AU AU2010332876A patent/AU2010332876A1/en not_active Abandoned
- 2010-12-16 WO PCT/EP2010/069896 patent/WO2011073321A1/en active Application Filing
- 2010-12-16 RU RU2012130069/10A patent/RU2012130069A/ru not_active Application Discontinuation
- 2010-12-16 US US13/516,834 patent/US20130017969A1/en not_active Abandoned
- 2010-12-16 CA CA2783693A patent/CA2783693A1/en not_active Abandoned
- 2010-12-16 BR BR112012014678A patent/BR112012014678A2/pt not_active IP Right Cessation
- 2010-12-16 MX MX2012006623A patent/MX2012006623A/es not_active Application Discontinuation
- 2010-12-16 IN IN6279DEN2012 patent/IN2012DN06279A/en unknown
- 2010-12-16 JP JP2012543751A patent/JP2013514070A/ja active Pending
- 2010-12-16 KR KR1020127018566A patent/KR20120115321A/ko not_active Application Discontinuation
- 2010-12-16 CN CN2010800573982A patent/CN102762742A/zh active Pending
- 2010-12-16 EP EP10788092A patent/EP2513328A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US20130017969A1 (en) | 2013-01-17 |
EP2513328A1 (en) | 2012-10-24 |
KR20120115321A (ko) | 2012-10-17 |
AU2010332876A1 (en) | 2012-07-12 |
IN2012DN06279A (pt) | 2015-09-25 |
JP2013514070A (ja) | 2013-04-25 |
MX2012006623A (es) | 2012-11-30 |
CN102762742A (zh) | 2012-10-31 |
CA2783693A1 (en) | 2011-06-23 |
RU2012130069A (ru) | 2014-01-27 |
WO2011073321A1 (en) | 2011-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012014678A2 (pt) | "uso do dna mrna, método para o diagnóstico da rosácea e método de monitoramento" | |
BRPI1009004A2 (pt) | método para integrar diagnóstico e tratamento para tecidos internos, e, sistema para integrar diagnóstico e tratamento para tecidos internos | |
BRPI0910608A2 (pt) | métodos e sistemas para avaliar resultados clínicos | |
BRPI1016147A2 (pt) | sistema intrauterino para uso no tratamento de uma condição médica, e, método para a fabricação de um sistema intrauterino | |
BRPI0917250A2 (pt) | sistema para detecção de tecido em um paciente, sistema para detectar característica de tecido em um paciente | |
BRPI1013625A2 (pt) | sistema, e método para determinar saúde de equipamento | |
BRPI0907279A2 (pt) | sistema de monitoramento fetal e método para o monitoramento fetal. | |
BRPI0914310A2 (pt) | sistemas, aparelhos, e métodos para prover eletroterapia não transcraniana | |
BR112012014418A2 (pt) | metodo para monitirar escovação dentaria e sistema | |
BR112013020352A2 (pt) | composto, composição farmacêutica, uso de um composto e método para tratar doença ou condição mediana por rorgamat num indivíduo | |
BRPI0806559A2 (pt) | Sistema e método de monitor para semeadeira | |
BRPI1009420A2 (pt) | axmi-001, axmi-002, axmi-030, e axmi-045; genes de toxina e métodos para seu uso | |
BRPI1010798A2 (pt) | fechamento, aparelho de retenção, e método de uso do mesmo | |
BR112013000745A2 (pt) | "método para diagnosticar ou detectar câncer colorretal em um individuo, método de tratamento e método para monitorar a eficacia de tratamento de câncer colorretal em um indivíduo" | |
BRPI0815677A2 (pt) | Catalisador de hidrogenação aromático e método de produção e uso do referido catalisador | |
BRPI1016158A2 (pt) | "sistema e método para monitorar um desempenho atlético, e, sistema e método de monitoramento do desempenho atlético." | |
BRPI1009381A2 (pt) | compostos, composição farmacêutica, método para tratar doença ou condição associada com função de trap1 em sujeito em necessidade do mesmo e uso de compostos e composição farmacêutica | |
BRPI0905851A2 (pt) | Métodos, sistemas, e dispositivos para realizar procedimentos eletrocirúrgicos | |
BR112012022879A2 (pt) | composto, composição farmacêutica, uso do composto e método de tratamento | |
BRPI0912426A2 (pt) | método executado por computador, computador, e sistema para uso com poço | |
BRPI1015922A2 (pt) | sistemas e métodos para testar analitos | |
BR112012005568A2 (pt) | aparelho e métodos para medir processos biológicos | |
BRPI1007779A2 (pt) | perexilina, método para tratamento de hcm, programa de tratamento para tratar hcm e uso da perexilina | |
BRPI0924215A2 (pt) | método e sistema para execução de medição | |
BR112012016882A2 (pt) | "monólitos de polímero poroso, processos para preparação e uso dos mesmos" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |